This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Quest Diagnostics Names Jim Davis, Senior Vice President, Diagnostic Solutions

MADISON, N.J., April 16, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, announced today that Jim Davis, a former vice president for three GE healthcare businesses, has joined Quest Diagnostics as Senior Vice President, Diagnostic Solutions.

In this role, Mr. Davis will lead the company's Diagnostic Solutions business. In this role, he will oversee Diagnostic Products, Insurer Services, Clinical Trials and Healthcare Information Technology. Mr. Davis also will lead the company's Employer Solutions business. He reports to Steve Rusckowski, president and CEO.

Mr. Davis will succeed Kathy Ordonez, who will work with Mr. Davis to ensure a smooth leadership transition before leaving the company.

"Jim brings tremendous experience at growing and restructuring complex healthcare businesses, including in diagnostics and healthcare information technology," said Mr. Rusckowski. "I want to thank Kathy for her leadership and many contributions, including her dedicated work in bringing Celera and Berkeley HeartLab into our portfolio. We wish her well in the days ahead."

Most recently, Mr. Davis served as CEO of InSightec, Inc., a medical device company that designs and develops ultrasound ablation devices that are guided by Magnetic Resonance Imaging (MRI) systems. Prior to that, he held vice president and general manager roles at GE's MRI, diagnostics imaging and healthcare information technology businesses, where he established a record for achieving growth and operational improvement. Prior to GE, Mr. Davis led the development of strategic and operating initiatives for clients of McKinsey.

Mr. Davis holds a business management degree from the Massachusetts Institute of Technology's Sloan School of Management, a master's of science degree in applied mathematics and operations research from MIT, and a bachelor's of science degree in in aeronautical engineering from the University of Michigan.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at Follow us at and .

Quest Diagnostics Contacts:  Wendy Bost (Media): 973-520-2800  Dan Haemmerle (Investors): 973-520-2900

SOURCE Quest Diagnostics Incorporated

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.26 -1.70%
FB $116.85 0.10%
GOOG $692.41 0.20%
TSLA $246.46 -0.50%
YHOO $36.36 -0.63%


Chart of I:DJI
DOW 17,740.91 -89.85 -0.50%
S&P 500 2,062.19 -13.62 -0.66%
NASDAQ 4,774.2780 -31.0130 -0.65%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs